JP Morgan Initiates Coverage on Legend Biotech Corporation (LEGN) with Neutral
Rating Change JP Morgan analysts initiated coverage on Legend Biotech Corporation (NASDAQ:LEGN) with a Neutral rating on July 13, 2026. Market Context Legend Biotech Corporation…
Read more
